Organic Sales Growth: 1.6% overall; 5.4% in Americas and Asia; -5.4% in Europe and Australia. Acquisition Sales Growth: 10.5% increase. Adjusted Earnings Per Share (EPS): Increased by 11.9% to USD1.22. Gross Profit Margin: 51%, with potential adjustment to 51.3% excluding restructuring costs. SG&A Expenses: USD108.7 million, 28.4% of sales; adjusted to 26.4% excluding certain costs. R&D Expense: USD19.2 million, an increase of 8.5% from the previous year. Pre-Tax Earnings: Increased by 11.5% to USD74.4 million, excluding certain costs. Net Income: Increased from USD50.9 million to USD52.3 million. Operating Cash Flow: USD59.9 million, compared to USD72.7 million last year. Free Cash Flow: USD55.6 million, compared to USD64.4 million last year. Cash Position: USD49.3 million as of April 30th. Dividends and Share Buybacks: USD44.5 million returned to shareholders. Tariff Impact: USD3 million in incremental tariff expense in Q3. Adjusted EPS Guidance: Tightened to USD4.48 to USD4.63 per share for the fiscal year. Warning! GuruFocus has detected 7 Warning Sign with BRC. Release Date: May 16, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Brady Corp (NYSE:BRC) reported a record high adjusted earnings per share, growing by 11.9% in the quarter. Organic sales growth was strong in the Americas and Asia regions, with a 5.4% increase. The company successfully increased its investment in R&D by more than 8%, supporting future product development. Brady Corp (NYSE:BRC) completed the acquisition of Funai's microfluidic solution business, enhancing its product portfolio. The company maintained a strong financial position, allowing for continued investment in organic growth and strategic acquisitions. Negative Points Organic sales in Europe and Australia declined by 5.4% due to a challenging macroeconomic environment. The company faced incremental tariff expenses, impacting earnings by approximately USD3 million in the third quarter. Free cash flow decreased from USD64.4 million in last year's Q3 to USD55.6 million in the current quarter. Gross profit margin slightly decreased to 51% from 51.6% in the previous year, partly due to restructuring expenses. Brady Corp (NYSE:BRC) had to reduce headcounts in China and Europe to address economic challenges and improve efficiency. Q & A Highlights Q: Are you seeing any impact on the top line due to tariffs, such as demand destruction or additional revenue from manufacturing shifts? A: Russell Shaller, President and CEO, responded that there hasn't been any tariff-related demand destruction yet. Many industrial companies, including Brady, carry a couple of months' worth of inventory, so the full effect of tariffs hasn't been seen. There might be price increases to recapture tariff changes, which could lead to inflation or demand destruction depending on the tariff's extent. Story Continues Q: How sustainable are the recent SG&A reductions? Are these one-time items, or should we expect this as a new run rate? A: Russell Shaller explained that Brady has been on a long-term journey to reduce SG&A costs. While there might be some quarterly fluctuations, the goal is to continue driving down SG&A over the years by improving operational efficiency and spreading SG&A over a larger organization. Q: Can you elaborate on the opportunities provided by the recent acquisition in April? A: Russell Shaller noted that the acquisition of Funai's microfluidic solution business enhances Brady's capabilities in direct part marking. Funai has been a supplier for Brady, and their industrial inkjet cartridges are integrated into Brady's printers. This acquisition is seen as a growth opportunity, rounding out Brady's ability to offer complete marking solutions. Q: Why is there a difference in growth expectations for the Americas and Asia versus Europe in Q4? A: Russell Shaller mentioned that they anticipate a headwind from tariffs in the Americas, which hasn't fully materialized yet. In Europe, after a decline in Q3, they expect a moderate recovery in Q4, leading to flat performance. The expectation is that Europe will stabilize, while the Americas might face some challenges. Q: What is the current situation in China for Brady? A: Russell Shaller stated that China has been a challenging market, primarily serving multinationals rather than indigenous companies. Due to the exodus of multinationals, Brady has adjusted its operations, closing a facility in Beijing and maintaining three plants in China. The focus remains on serving Chinese customers, with China accounting for about 3% of Brady's revenue. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. View Comments
Brady Corp (BRC) Q3 2025 Earnings Call Highlights: Record EPS Growth Amid Global Challenges
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...